The five-year survival rate for women with stage I cancer is about 100 percent. A woman with stage II, like McBride, has a survival rate of about 93 percent with a good prognosis. For stage III, that number is 72 percent.
After her diagnosis, McBride learned that the type of cancer she had was HER2+, so her body would not accept immunotherapy or hormonal therapy as a viable treatment. McBride’s doctors scheduled her for a lumpectomy in addition to radiation and chemotherapy, she said.
In addition to the shock, McBride said that she wanted to start her therapies immediately, even though she had an idea about their daunting physiological effects.
“Unbelievably, I wanted to start chemo right away because you must have it to live,” McBride said. “But then, after all the denial and apprehension diminishes, you realize that the side-effects of chemotherapy aren’t that great, and you rethink your plan.”
There are short and long-term effects of both chemotherapy and radiation therapy, including fatigue, pain and sleep disorders, according to Susan G. Komen, a breast cancer research and advocacy organization.
McBride said that experienced similar side effects. "At first, I slept a lot," she said. "But after my first and second round of therapy, sleeping became harder and harder to do. The therapy affects your appetite and weight. There were a few times when I couldn't even walk from one room of my house to another one without taking shorts. breaks."